RxDoctor Payments Data

Justin Greiner

Sports Medicine · Omaha, NENPI 1578912226

Payments from drug & device makers

What this record shows

This record is dominated by education: $32,501 of the $47,354 with a category attached, or 68.6%. 9 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 40.9% of the total. Reporting peaked in 2021 at $22,404 and has fallen 95.6% since, to $987 in 2025. Among sports medicine clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,354in general payments, 2019–2025

Across 87 payments — averaging $544.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mid-atlantic Surgical Systems, LLC$19K
  • Arthrex$15K
  • Smith+Nephew$8K
  • Great Lakes Orthopedics$3K
  • Stryker$1K
  • Conetic Solutions, Inc.$820
  • plus $336 from 3 others

What the payments were for

  • Grants$10,00021%
  • Travel & lodging$2,4715%
  • Food & beverage$2,3825%
  • Education$32,50169%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,354 in reported general payments places this provider in the 95th percentile of 34 sports medicine providers in Nebraska.

See all sports medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$14,407
Medicare patients
75
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam56$311

Paid to pharmacies, not to this prescriber.

Other sports medicine in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →